Feng Hsiung - 25 Jun 2025 Form 4 Insider Report for Senti Biosciences, Inc. (SNTI)

Role
Director
Signature
/s/ Robert Cutler, attorney-in-fact
Issuer symbol
SNTI
Transactions as of
25 Jun 2025
Transactions value $
$0
Form type
4
Filing time
27 Jun 2025, 19:55:03 UTC
Previous filing
11 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hsiung Feng Director C/O SENTI BIOSCIENCES, INC., 2 CORPORATE DRIVE FIRST FLOOR, SOUTH SAN FRANCISCO /s/ Robert Cutler, attorney-in-fact 27 Jun 2025 0002059159

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNTI Stock Option (Right to Buy) Award $0 +22K $0.00 22K 25 Jun 2025 Common Stock 22K $2.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2026 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date.